IndraLab

Statements

Pyridine inhibits MAP3K7. 2 / 2

| 2

reach

"Over the dosing interval, ABC-FP showed a calculated 62% tumor growth inhibition on day 15, indicating some potential for a TAK1 inhibitor to be useful in the treatment of ovarian cancer.In summary, w[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

23856049

➶

reach

"More recently, a series of 7-aminofuro [2,3-c] pyridine inhibitors of TAK1 have been described [XREF_BIBR]."

25557171

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Pyridine inhibits MAP3K7. 2 / 2

INDRA sources:

Databases

Reading